Search Results for “H19-423_V1.0 Latest Test Testking 🍀 H19-423_V1.0 Practical Information 📄 H19-423_V1.0 Test Price 🕔 Go to website ☀ www.pdfvce.com ️☀️ open and search for ➠ H19-423_V1.0 🠰 to download for free 🎤H19-423_V1.0 Download Pdf” – Page 13

Activation of the Prostaglandin E2 receptor EP2 prevents house dust mite-induced airway hyper responsiveness and inflammation by restrainingmast cells’ activity

218

Serra-Pages, M., Torres, R., Plaza, J., Herrerias, A., Costa-Farré, C., Jiménez, M., Maurer, M. Picado, C., and de Mora, F.+: Activation of the prostaglandin E2 receptor EP2 prevents house dust mite-induced airway hyperresponsiveness and inflammation by restraining mast cells activity. Clin. Exp. Allergy 2015: 45; 1590-1600. IF: 5.58

o.218

154	Kolkhir, P., Altrichter, S., Muñoz, M., Hawro, T., and Maurer, M.+: New treatments for chronic urticaria. Ann. Allergy Asthma Immunol. 2020: 124; 2-12. IF: 6.35

r.154

Definition, aims, and implementation of GA²LEN urticaria centers of reference and excellence

258

Maurer, M., Metz, M., Bindslev-Jensen, C., Bousquet, J., Canonica, G. W., Church, M. K., Godse, K. V., Grattan, C. E., Hide, M., Kocatürk, E., Magerl, M., Makris, M., Meshkova, R., Saini, S. S., Sussman, G., Toubi, E., Zhao, Z., Zuberbier, T.+, and Gimenez-Arnau, A.: Definition, aims, and implementation of GA²LEN urticaria centers of reference and excellence. Allergy 2016: 71; 1210-1218. IF: 7.36

101.	Mitchell, S., Balp, M. M., Samuel, M., McBride, D., and Maurer, M.: Systematic review of treatments for chronic spontaneous urticaria with inadequate response to licensed first-line treatments. Int. J. Dermatol. 2015: 54; 1088-1104. IF: 1.41

r.101

38.	Krause, K., Zuberbier, T. and Maurer, M.: Modern approaches to the diagnosis and treatment of cold contact urticaria. Curr. Allergy Asthm. 2010: 10; 243-249. IF: 2.34

Eosinopenia, in Chronic Spontaneous Urticaria, Is Associated with High Disease Activity, Autoimmunity, and Poor Response to Treatment

372

Kolkhir, P., Church, M. K., Altrichter, S., Stahl Skov, P., Hawro, T., Frischbutter, S., Metz, M., and Maurer, M.+: Eosinopenia, in chronic spontaneous urticaria, is associated with high disease activity, autoimmunity and poor response to treatment. J. Allergy Clin. Immunol. Pract. 2020: 8; 318-325. IF: 8.86

o.372

243	Siebenhaar, F., Melde, A., Magerl, M., Zuberbier, T., Church, M. K.+, and Maurer, M.: Histamine intolerance in patients with chronic spontaneous urticaria. J. Eur. Acad. Dermatol. Venereol. 2016: 30; 1774-1777. IF: 3.52

392.	Sommer, R.⁺, Silva, N., Langenbruch, A., Maurer, M., Staubach, P., and Augustin, M.: Characteristics and determinants of patient burden and needs in the treatment of chronic spontaneous urticaria. Eur. J. Dermatol. 2020: 30; 259-266. IF: 3.33

o.392

165	Krause, K., Spohr, A., Zuberbier, T., Church. M. K.+, and Maurer, M.: Up-dosing with bilastine results in improved effectiveness in cold contact urticaria. Allergy 2013: 68; 921-928. IF: 5.99

245	Zazzali, J. L., Kaplan, A., Maurer, M. Raimundo, K., Trzaskoma, B., Solari, P. G., Antonova, E.+, Mendelson, M., and Rosén, K.: Angioedema in the omalizumab chronic idiopathic/spontaneous urticaria pivotal studies. Ann. Allergy Asthma Immunol. 2016: 117; 370-377. IF: 3.72

Results